Michels, Monique http://orcid.org/0000-0001-8440-1976
Jesus, Gabriel Fernandes Alves
Abatti, Mariane Rocha
Córneo, Emily
Cucker, Luana
de Medeiros Borges, Heloisa
da Silva Matos, Natan
Rocha, Luana Bezerra
Dias, Rodrigo
Simon, Carla Sasso
Voytena, Ana Paula Lorenzen
Rossetto, Marina
Ramlov, Fernanda
Dal-Pizzol, Felipe
Funding for this research was provided by:
GABBIA
unesc
Article History
Received: 6 December 2021
Accepted: 29 May 2022
First Online: 8 June 2022
Declarations
:
: All authors listed have contributed sufficiently to the review to be included as authors, and all those who are qualified to be authors are listed in the author byline.
: The manuscript has been read and approved by all named authors, and we confirm that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We understand that the corresponding author is the sole contact for the Editorial process. He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs.
: Gabbia Biotechnology are developing probiotics strains for commercial purposes. Gabriel Jesus, Fernanda Ramlov, Marina Rosseto and Ana Paula Voytena are members of Gabbia Biotechnology. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.